We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current IMMPF market cap is 28.34M. The company's latest EPS is GBP -0.0114 and P/E is -2.00.
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 81k | 78k | 127k | 118k | 0 |
Operating Income | -8.08M | -6.81M | -5.59M | -6.59M | -3.03M |
Net Income | -7.21M | -6.12M | -6.86M | -8.17M | -3.81M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Assets | 8.66M | 5.8M | 10.92M | 6M | 3.98M |
Total Liabilities | 1.04M | 532k | 1.26M | 1.58M | 1.45M |
Total Equity | 7.62M | 5.27M | 9.66M | 4.41M | 2.52M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Operating | -4.72M | -4.22M | -3.33M | -4.83M | -2.35M |
Investing | -2.09M | -101k | -569k | -50k | -77k |
Financing | 9.15M | 326k | 8.37M | 702k | 1.55M |
Market Cap | 28.34M |
Price to Earnings Ratio | -2.00 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 11.4 |
Price to Book Ratio | 3.01 |
Dividend Yield | - |
Shares Outstanding | 333.4M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0 (0%) |
Company Name | Immupharma PLC (PK) |
Address |
one bartholomew close london EC1A 7BL |
Website | https://www.immupharma.com |
Industry | finance diversified (F) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions